Medical education
Accredited CME for continuing professional development
Accredited TK2d symposium
Diagnosing and treating TK2d – 1 CME credit
Accredited symposium: Elevating LOPD care
Join Prof. Schoser, Dr. Mozaffar and Dr. Kishnani for an accredited symposium focused on translating patient perspectives into effective care.
Alpha-1 antitrypsin deficiency
Expert insights on AATD-associated liver disease
ASCO: Treatment selection in Ph+ ALL
EBAC – Earn 1 CME point
COMy: Managing R/R multiple myeloma in older adults
EBAC – Earn 1 CME point
AATD liver disease podcast series
1.5 CME credits: Experts share insights on AATD
Learning Zones
Advances in HS
EHSF 2024: Surgical updates and changes to practice
Advances in Lymphoma
Information on current lymphoma care and treatments for classic Hodgkin lymphoma (cHL), PTCL subtypes, relapsed DLBCL, and B-NHL.
Alopecia areata: Progressing practice
Latest treatment options and patient insights
Alpha-1 antitrypsin deficiency
Expert insights on AATD-associated liver disease
Anti-CGRP Therapies for Migraine
Learn about unmet needs and disease burden associated with migraine, the role of CGRP in its pathophysiology, and anti-CGRP therapies for acute and prophylactic treatment of migraine.
Antiplatelet Therapy in ACS: Choices and Controversies
Acute coronary syndrome (ACS) represents a leading cause of mortality and morbidity worldwide. Antiplatelet therapy is a cornerstone of ACS management.
CDK4/6 Inhibitors in Breast Cancer
Are you familiar with the clinical trial evidence that could help you to select the best cyclin dependent kinase 4/6 (CDK4/6) inhibitor for your metastatic breast cancer patient?
Chronic Kidney Disease Learning Zone
Chronic Kidney Disease (CKD) is a disease that can often lead to a need for haemodialysis and kidney transplantation. New CKD treatments are emerging which focus on delaying CKD disease progression and the need for transplantation.
Expert insights on CSU management
The latest in CSU diagnosis and care
Chronic Inflammatory Demyelinating Polyneuropathy
Gain a comprehensive overview of CIDP, including diagnostic challenges and how to apply the latest guidelines in practice.
Glaucoma Learning Zone
Learn more about risk factors and symptoms of glaucoma, watch expert videos on glaucoma screening and diagnosis, and test your knowledge of glaucoma treatments with a series of patient case studies and quizzes.
Growth Hormone Deficiency
An introduction to growth hormone deficiency (GHD), summarising the content. A quiz on GHD, followed by links to pages on GHD symptoms, diagnosis and treatment landscape.
Hidradenitis Suppurativa Learning Zone
Hidradenitis suppurativa Learning Zone: explore HS diagnosis, HS epidemiology, burden of HS, pathophysiology and future treatments for HS
HLH/MAS: A multifaceted syndrome
Overview of secondary HLH/MAS
Lupus Learning Zone
Systemic lupus erythematosus (SLE) is a highly burdensome disease, with the worst affected SLE patients suffering refractory disease and organ damage accrual.
Managing High-Risk NMIBC
Expert and patient insights on high-risk NMIBC, including relevant clinical trial data and standout congress sessions.
mCRPC in Focus
Unmet needs in the management of mCRPC, with a focus on treatments
Multiple Sclerosis (MS) Learning Zone
Choosing the right treatment is critical to managing multiple sclerosis (MS). Consider your options with the latest data from over 40 MS clinical trial and congress resources.
Myasthenia Gravis Learning Zone
Medical education resources focused on identifying early symptoms of myasthenia gravis, available treatments and information about the latest findings in new therapy pathways
Pompe Disease: Key findings from WMS 2022
Review developments in Pompe disease, expert opinion and discussion, and more in the following pages. Highlights and forthcoming expert content focus on the 2022 World Muscle Society Congress which was held in Halifax, Canada 11–15 October.
Psoriasis Academy
When it comes to psoriasis, a knowledgeable healthcare professional is highly valued by patients (Pariser et al., 2016). With this in mind, we created The Psoriasis Academy, an online hub featuring succinct and easily accessible information for all healthcare professionals who want to know more about psoriasis and keep up to date with the latest developments.
Relapsing multiple sclerosis
Congress coverage of ACTRIMS/AAN, ECTRIMS, MS Medical Grand Rounds, triMS, ECF and EAN on topics including quality of life in relapsing multiple sclerosis (RMS), safety and efficacy of therapies, pregnancy planning in MS and real-world data of disease-modifying therapies (DMTs).
Supportive Care in Oncology Learning Zone
Supportive care in oncology from a multidisciplinary team involves caring for patients with cancer, treatment adherence and adverse effect management.
Think Thrombosis
Latest data and clinical guidance
Roundtable: Biologics in plaque psoriasis
Watch expert roundtable on the use of biologics in moderate-to-severe plaque psoriasis, chaired by Professor Luis Puig.
Introducing vasomotor symptoms
Vasomotor symptoms (VMS) remain one of the most impactful aspects of menopause.
Learn more about their impact and the treatment options available with "VMS breakthroughs" a 4 article series focused on VMS
Myasthenia gravis at EAN 2024
Read about myasthenia gravis at the European Academy of Neurology (EAN) Congress 2024 in this three article series covering personalised treatments, the impact of sex on MG outcomes, and emerging treatment options for MG, including complement inhibitors and neonatal fragment crystallisable receptor (FcRn) blockers.
AL amyloidosis interactive patient journey
Make your own clinical decisions for managing a patient with AL amyloidosis in this interactive patient journey, guided by additional management tips provided by Dr. Shaji Kumar every step of the way.
HER2-low, PARP inhibitors, and more from SABCS 2022
Catch up on the latest developments in breast cancer from San Antonio with our coverage of SABCS 2022.
Other insights
